top of page

Research Publications
Our Numbers
500+
Publications
49,600+
Total Times Cited
12,119
Most Times Cited
12+ Mil.
number of single cells analyzed
620 TB
of data generated
10.000+
Yearly Patient Screens
Publication List
Xie S, Bao D, Xiao Y, Li H, Guo M, Dai B, Liu S, Huang J, Li M, Ding L, Meng Q, Lv CL, Distler JHW, Luo H, Zhu H. Alternative splicing and intron retention: Their profiles and roles in cutaneous fibrosis of systemic sclerosis. J Autoimmun. 2024 Dec;149:103306. doi: 10.1016/j.jaut.2024.103306. Epub 2024 Sep 12.PMID: 39265192 |
Wyss A, Jordan S, Graf N, Carreira PE, Distler J, Cerinic MM, Siegert E, Henes J, Zanatta E, Riccieri V, Truchetet ME, Oksel F, Li M, Kucharz EJ, Eyerich K, Del Galdo F, Vonk MC, Vold AH, Gabrielli A, Distler O; EUSTAR collaborators Does regression of skin thickening predict improvement of internal organ involvement and survival in patients with diffuse cutaneous systemic sclerosis? A EUSTAR analysis. Arthritis Res Ther. 2024 Oct 31;26(1):187. doi: 10.1186/s13075-024-03418-2.PMID: 39482761 |
Rius Rigau A, Liang M, Devakumar V, Neelagar R, Matei AE, Györfi AH, Bergmann C, Filla T, Fedorchenko V, Schett G, Distler JHW, Li YN. Imaging mass cytometry-based characterisation of fibroblast subsets and their cellular niches in systemic sclerosis. Ann Rheum Dis. 2024 Oct 23:ard-2024-226336. doi: 10.1136/ard-2024-226336. Online ahead of print.PMID: 39442983 |
Albu MT, Matei AE, Distler JHW, Giesel FL, Mori Y. Fibroblast activation protein inhibitor PET/CT as an emerging diagnostic modality in interstitial lung disease and other fibrotic conditions. Rheumatol Immunol Res. 2024 Oct 21;5(3):152-156. doi: 10.2478/rir-2024-0021. eCollection 2024 Sep.PMID: 39439976 |
Page 1 of 1
bottom of page
